| Saturday 18th November |
| 09:55‑16:15 |
| 09:55‑10:00 | Introduction |
| 10:00‑10:45 | A human model of COPD |
| 10:45‑11:30 | A weak link in the lung |
| 11:30‑12:15 | Pulmonary Gas Exchange |
| 12:15‑13:15 | Lunch (complimentary lunchbox provided) |
| 13:15‑14:00 | Small airways disease, ventilation inhomogeneity and airway hyperresponsiveness |
| 14:00‑14:45 | Obstructive sleep apnea: what is the evidence for vascular pathogenesis? |
| 14:45‑15:30 | Emotion and Breathing |
| 15:30‑16:15 | Commentaries |
| Otemachi, Tokyo |
| Sunday 19th November |
| 09:00‑15:50 | Educational Seminar hosted by JRS | Room A |
| 09:00‑15:50 | Post-graduate Courses
| 09:00‑10:20 | PG-1 Non-invasive Ventilation |
| 10:30‑11:50 | PG-2 Chemotherapy |
| 11:50‑13:00 | Lunch (complimentary lunchbox provided) |
| 13:00‑14:20 | PG-3 Pathogenesis of COPD |
| 14:30‑15:50 | PG-4 Pathogenesis of Bronchial Asthma |
| Room B‑1 |
| 13:00‑15:30 | Creating an Academic Career in Respiratory Medicine | MAIN HALL |
| 14:00‑15:30 | Press Conference (GOLD) | Room 510 |
| 16:00‑17:00 | Ann Woolcock Memorial Lecture Airway Hyperresponsiveness: Have we Answered Dr. Woolcock's Question? | MAIN HALL |
| 17:00‑17:30 | Kyoto video |
| 17:30‑18:30 | Opening Ceremony |
| 18:30‑ | Welcome Reception | Sakura |
| Monday 20th November |
| 08:00‑08:50 | Meet the Experts | Rooms H, I, J, K |
| 09:00‑18:00 | Poster Viewing | Event Hall |
| 09:00‑11:20 | GOLD Revision 2006 | MAIN HALL |
| 09:00‑11:20 | S-1 Cutting Edge Science and New Diagnostic Tools for Respiratory Disease | Room A |
| 09:00‑11:20 | WS-1 Non-invasive Positive Pressure Ventilation: Principles and Practice | Room B‑1 |
| 09:00‑11:20 | S-2 Recent Trends of Idiopathic Interstitial Pneumonias (IIPs) | Room B‑2 |
| 09:00‑11:20 | Oral Presentations | Room C‑1 |
| 11:30‑12:30 | Poster Symposium and
Poster Presentation | Event Hall |
| 12:40‑13:30 | LS-1 Lung hyperinflation and comorbidities in COPD | MAIN HALL |
| 12:40‑13:30 | LS-2 Efficacy of respiratory quinolones against community-acquired pneumonia | Room B‑1 |
| 12:40‑13:30 | LS-3 Diagnosis and management of PAH | Room B‑2 |
| 12:40‑13:30 | LS-4 Early intervention in bronchial asthma | Room C‑1 |
| 12:40‑13:30 | LS-5 Chemotherapy for outpatients with lung cancer in Japan | Room C‑2 |
| 12:40‑13:30 | LS-6 A new concept of β2-agonist therapy in asthma and COPD | Room D |
| 13:35‑14:00 | Assembly Meetings | Room C‑2 |
| 14:00‑14:20 | Annual General Meeting |
| 14:20‑15:20 | Harasawa Memorial Lecture | MAIN HALL |
| 15:20‑17:20 | ATS Session | Room A |
| 15:20‑17:20 | S-3 Asthma Insights and Asthma Management in the Asian Pacific Region (APSR/AAAF joint symposium) | Room B‑1 |
| 15:20‑17:20 | WONCA Session | Room B‑2 |
| 15:20‑17:20 | Oral Presentations | Room C‑1 |
| 17:30‑19:30 | ES-1 Approaches to exacerbation of COPD | MAIN HALL |
| 17:30‑19:30 | ES-2 New Wind in managing COPD | Room A |
| 17:30‑19:30 | ES-3 Diagnostic and therapeutic approach to pulmonary thromboembolism | Room B‑1 |
| 17:30‑18:30 | SS-1 Molecular Targeting Therapy in Lung Cancer, Current & Future Perspectives | Room B‑2 |
| 17:30‑19:30 | ES-4 The Evolution of Asthma Management: Are We Achieving Optimal Control? | Sakura |
| 17:30‑19:30 | ES-5 Respiratory quinolones: Update on management of RTIs | Room E |
| Tuesday 21st November |
| 08:00‑08:50 | Meet the Experts | Rooms H, I, J, K |
| 09:00‑18:00 | Poster Viewing | Event Hall |
| 09:00‑11:20 | WS-2 Update on Radiologic Correlation of Pulmonary Disease | Room A |
| 09:00‑11:20 | S-4 Update on the Pathogenesis and the Therapy of COPD | Room B‑1 |
| 09:00‑11:20 | S-5 Preparedness of New Influenza | Room B‑2 |
| 09:00‑11:20 | Oral Presentations | Room C‑1 |
| 11:30‑12:30 | Poster Symposium and
Poster Presentation | Event Hall |
| 12:40‑13:30 | LS-7 Unmet needs in asthma: filling the gap | Room A |
| 12:40‑13:30 | LS-8 Sleep in COPD and the role of noninvasive ventilation | Room B‑1 |
| 12:40‑13:30 | LS-9 Evaluation of clarithromycin (CAM) in the management of patients with pulmonary Mycobacterium Avium Complex (MAC) | Room B‑2 |
| 12:40‑13:30 | LS-10 Science of lung auscultation | Room C‑1 |
| 12:40‑13:30 | LS-11 Reassessment of theophylline: its role in asthma management | Room C‑2 |
| 12:40‑13:30 | LS-12 Roles of long-acting bronchodilators in COPD | Room D |
| 12:40‑13:30 | LS-13 Current status of EGFR-TKI for NSCLC | Room E |
| 13:40‑15:40 | ERS Session | Room A |
| 13:40‑15:10 | MS-1 Tuberculosis in Asia Today: Challenges and Development | Room B‑1 |
| 13:40‑15:10 | MS-2 Update on Pulmonary Arterial Hypertension | Room B‑1 |
| 13:40‑16:50 | Oral Presentations | Room C‑1 |
| 15:20‑16:50 | MS-3 Environmental and Occupational Lung Disease | Room B‑2 |
| 15:20‑16:50 | S-6 Recent Advances in Lung Cancer Research | Room B‑2 |
| 15:50‑16:50 | GARD Session | Room A |
| 17:00‑19:00 | ES-6 Affecting the mortality in COPD: Is the dream becoming a reality? | MAIN HALL |
| 17:00‑19:00 | ES-7 Chronic cough: pathogenesis and treatment | Room A |
| 17:00‑19:00 | ES-8 Acute Lung Injury and Role of Neutrophil Elastase | Room B‑1 |
| 17:00‑19:00 | ES-9 Modern treatment of RTI with moxifloxacin, a new respiratory quinolone | Room D |
| 17:00‑18:00 | SS-2 Optimum treatment for advanced lung cancer | Room B‑2 |
| 17:35‑18:35 | SS-3 Clinicoradiological diagnosis of respiratory infections | Room C‑1 |
| 19:30‑ | Banquet | Sakura room |
| Wednesday 22nd November |
| 08:00‑08:50 | Meet the Experts | Rooms H, I, J, K |
| 09:00‑11:00 | S-7 Complemantary Medicine for Respiratory Diseases in Asian Pacific Area | Room A |
| 09:00‑10:00 | PL-1 International Standards for Tuberculosis Care | MAIN HALL |
| 10:00‑11:00 | PL-2 The Pathogenesis of Small Airway Obstruction and Emphysema in COPD |
| 11:00‑13:00 | Presidential Symposium (ATS, ACCP, ERS, APSR, ALAT) |
| 13:00‑14:00 | Closing Ceremony |
